$Cingulate (CING.US)$ The drug is designed using Cingulate's...
The drug is designed using Cingulate's Precision Timed Release technology, which allows for three precisely timed releases of medication throughout the day. This innovation is intended to provide patients with a full day's efficacy from just one tablet, addressing a significant challenge in ADHD treatment where maintaining medication effectiveness throughout an active day has been difficult with existing therapies.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
blessings u OP : This patent covers up to 30 European territories, including the United Kingdom, marking a crucial step in Cingulate's efforts to solidify its presence in the global ADHD market.
blessings u OP : European ADHD Gender Study
Another study, called the European ADORE study, took place over a period of 24 months. It includes research pulled from 10 EU countries ages 6-18 years. Out of 1478 children studied, boys with ADHD totaled 1222, which make up 84.3% of this group, and girls 231, which equals 15.7%.
Gender ratios indicated by countries included in the ADORE study measured 1:3 in females and 1:16 in males. Data reveals more diagnoses of ADHD in adult males than adult females in many locations. However, the ratio of males to females with ADHD has decreased with age.
convivial Penguin_29 : what's the likelihood of gets patents in America? we love our drugs. how high would it go then?
blessings u OP convivial Penguin_29 : The population of the European Union plus the United Kingdom is about 0.51 billion, far surpassing that of the United States. The population with ADHD in the EU is about 30 million.
Lnova : hey, thank you for this info. now I understand the changes in the share price better. I appreciate you sharing it
makes sense now
blessings u OP convivial Penguin_29 : Around thirty-five yuan. In the long run, it is also possible that it will reach more than 100 yuan depending on the subsequent issuance of shares and performance.
blessings u OP convivial Penguin_29 : Because the total share capital is only over 900,000 shares. It is necessary to issue shares and raise capital to support production and sales.
blessings u OP Lnova : welcome
blessings u OP convivial Penguin_29 : US patents depend on the progress of the application. Eighty percent likely.
BeastMY : Important is their PTR innovation, basically they can work out deal with many API holder
View more comments...